Prevention of central venous catheter-related infection: Update

British Journal of Nursing

Volumn 19, Issue 2, 2010, Pages 78-87

  Casey, Anna L ^a   Elliott, Tom Sj ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Antimicrobial devices; Care bundle; Catheter related infection; Central venous catheter; Infection control; IV therapy

Indexed keywords

ANTIINFECTIVE AGENT; TOPICAL ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BANDAGE; CENTRAL VENOUS CATHETERIZATION; CROSS INFECTION; DRUG DELIVERY SYSTEM; EQUIPMENT; HUMAN; INDWELLING CATHETER; INFECTION; INFECTION CONTROL; INSTRUMENTATION; METHODOLOGY; MICROBIOLOGY; NURSING; REVIEW; SKIN;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BANDAGES; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CROSS INFECTION; DRUG DELIVERY SYSTEMS; EQUIPMENT CONTAMINATION; HUMANS; INFECTION CONTROL; PROSTHESIS-RELATED INFECTIONS; SKIN;

EID: 77951885466     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2010.19.2.46289     Document Type: Article

References (48)

1. Adams D, Elliott TSJ (2007) Skin antiseptics used prior to intravascular catheter insertion. Br J Nurs 16(5): 278-80
2. Blot SI, Depuydt P, Annemans L et al (2005) Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 41(11): 1591-8
3. Casey AL, Elliott TS (2007) Infection risks associated with needleless intravenous access devices. Nurs Stand 22(11): 38-44
4. Casey AL, Mermel LA, Nightingale P, Elliott TS (2008) Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 8(12): 763-76
5. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S (2002) Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 136(11): 792-801
6. Chatzinikolaou I, Zipf TF, Hanna H et al (2003) Minocycline- ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36(1): 116-19
7. Coello R, Charlett A, Ward V et al (2003) Device-related sources of bacteraemia in English hospitals - opportunities for the prevention of hospital-acquired bacteraemia. J Hosp Infect 53(1): 46-57
8. Cook D, Randolph A, Kernerman et al (1997) Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 25(8): 1417-24
9. Cookson ST, Ihrig M, O'Mara EM et al (1998) Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol 19(1): 23-7
10. Department of Health (2007) Saving Lives: Reducing Infection, Delivering Clean and Safe Care. High Impact Intervention No 1: Central Venous Catheter Care Bundle. DH, London. Available at: http://tinyurl.com/yac6tm2 (last accessed 14 December 2009)
11. Dezfulian C, Lavelle J, Nallamothu BK, Kaufman SR, Saint S (2003) Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis. Crit Care Med 31(9): 2385-90
12. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA (2001) Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 136(2): 229-34 (Pubitemid 32143849)
13. Elliott TSJ (1988) Intravascular device infections. J Med Microbiol 27(3): 161-7
14. Falagas ME, Fragoulis K, Bliziotis IA, Chatzinikolaou I (2007) Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 59(3): 359-69
15. Farkas JC, Liu N, Bleriot JP, Chevret S, Goldstein FW, Carlet J (1992) Single- versus triple-lumen central catheterrelated sepsis: a prospective randomized study in a critically ill population. Am J Med 93(3): 277-82
16. Gillies D, O'Riordan L, Carr D, Frost J, Gunning R, O'Brien I (2003) Gauze and tape and transparent dressings for central venous catheters. Cochrane Database Syst Rev (4): CD003827
17. Hamilton HC, Foxcroft DR (2007) Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database Syst Rev (3): CD004084
18. Ho KM, Litton E (2006) Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 58(2): 281-7
19. Jarvis W, Sherertz R, Perl T, Bradley K, Giannetta E (2005) Increased central venous catheter-associated bloodstream infection rates temporally associated with changing from a split septum to a Leur-access mechanical valve needleless device: a nationwide outbreak? Am J Infect Control 33: e14-15
20. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK (2000) Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest 117(1): 178-83
21. Kellerman S, Shay DK, Howard J et al (1996) Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr 129(5): 711-17
22. Lorente L, Jimenez A, Garcia C et al (2008) Catheterrelated bacteremia from femoral and central internal jugular venous access. Eur J Clin Microbiol Infect Dis 27(9): 867-71
23. Luchsinger B, Meyer T, Kelsey M (2009) Evaluating a needleless connector treated with antimicrobial agents using two different in vitro assays. Presented at the 19th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. San Diego, California, March 2009
24. Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81(9): 1159-71
25. Maki DG, Stahl J, Jacobson C, Pyrek J (2008) A novel integrated chlorhexidine-impregnated transparent dressing for prevention of catheter-related bloodstream infection: a prospective comparative study in healthy volunteers. Presented at the 18th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America. Orlando, Florida, April 2008
26. Maragakis LL, Bradley KL, Song X et al (2007) Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol 27(1): 67-70
27. McDonald LC, Banerjee SN, Jarvis WR (1998) Lineassociated bloodstream infections in pediatric intensivecare- unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol 19(10): 772-7
28. Merrer J, De Jonghe B, Golliot F et al (2001) Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 286(6): 700-7
29. O'Grady NP, Alexander M, Dellinger EP et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51(RR-10): 1-29
30. Opilla MT, Kirby DF, Edmond MB (2007) Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 31(4): 302-5
31. Pittet D, Allegranzi B, Boyce J (2009) The World Health Organization Guidelines on Hand Hygiene in Healthcare and their consensus recommendations. Infect Control Hosp Epidemiol 30(7): 611-22
32. Pratt RJ, Pellowe CM, Wilson JA et al (2007) epic2: National evidence-based guidelines for preventing healthcareassociated infections in NHS hospitals in England. J Hosp Infect 65(Suppl 1): S1-64
33. Raad I, Hohn DC, Gilbreath BJ et al (1994) Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15(4 Pt 1): 231-8
34. Raad I, Hachem R, Tcholakian RK, Sherertz R (2002) Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 46(2): 327-32
35. Raad I, Hanna H, Maki D (2007) Intravascular catheterrelated infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7(10): 645-57
36. Raad I, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R (2008) The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 21(4): 385-92
37. Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia, a cohort and casecontrol study in critically ill patients. Am J Respir Crit Care Med 163(7): 1584-90
38. Rupp ME, Lisco SJ, Lipsett PA et al (2005) Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheterrelated infections: a randomized, controlled trial. Ann Intern Med 143(8): 570-80
39. Rupp ME, Struve PS, Burleson GR, Thorn MD (2008) Effect of a silver-coated, luer activated intravenous catheter connector valve in a rat model of MRSA central venous catheter associated bloodstream infection (CVCBSI). Presented at the 48th Annual ICAAC/IDSA 46th British Journal of Nursing, 2010, Vol 19, No 2 87 Annual Meeting. Washington DC, October 2008
40. Ruschulte H, Franke M, Gastmeier P et al (2009) Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol 88(3): 267-72
41. Sadfar N, Maki DG (2006) Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43(4): 474-84
42. Soothill JS, Bravery K, Ho A, Macqueen S, Collins J, Lock P (2009) A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: A pediatric single center before/ after study on a hemopoietic stem cell transplant ward. Am J Infect Control 37(8): 626-30
43. Stephens R, Mythen M, Kallis P, Davies DW, Egner W, Rickards A (2001) Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidinesulphadiazine- coated central venous catheter. Br J Anaesth 87(2): 306-8
44. Timsit JF, Schwebel C, Bouadma L et al (2009) Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically-ill adults: a randomized controlled trial. JAMA 301(12): 1231-41
45. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ (2006) Attributable cost of catheter-associated bloodstream infections among intensive care patients in a non-teaching hospital. Crit Care Med 34(8): 2084-9
46. Yebenes JC, Vidaur L, Serra-Prat M et al (2004) Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomised controlled trial. Am J Infect Control 32(5): 291-5
47. Yeung C, May J, Hughes R (1988) Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol 9(4): 154-8
48. Zurcher M, Tramer MR, Walder B (2004) Colonization and bloodstream infection with single- versus multi-lumen central venous catheters: a quantitative systemic review. Anesth Analg 99(1): 177-82